ko pathway ratio_in_study ratio_in_pop p_value ko05162 Measles 3/6 120/7206 8.68520269399e-05 ko05203 Viral carcinogenesis 3/6 277/7206 0.00103088197194 ko05212 Pancreatic cancer 2/6 83/7206 0.00190809886565 ko05220 Chronic myeloid leukemia 2/6 85/7206 0.0020002489361 ko05222 Small cell lung cancer 2/6 89/7206 0.00219084785916 ko04660 T cell receptor signaling pathway 2/6 124/7206 0.00421119105411 ko04933 AGE-RAGE signaling pathway in diabetic complications 2/6 135/7206 0.00497433563975 ko05161 Hepatitis B 2/6 173/7206 0.00806692044461 ko05418 Fluid shear stress and atherosclerosis 2/6 173/7206 0.00806692044461 ko04218 Cellular senescence 2/6 177/7206 0.00843275761946 ko05167 Kaposi's sarcoma-associated herpesvirus infection 2/6 191/7206 0.00977228452194 ko05166 HTLV-I infection 2/6 292/7206 0.0220304097941 ko01523 Antifolate resistance 1/6 30/7206 0.024729130984 ko04623 Cytosolic DNA-sensing pathway 1/6 41/7206 0.0336678118474 ko04151 PI3K-Akt signaling pathway 2/6 390/7206 0.0379052053679 ko05219 Bladder cancer 1/6 48/7206 0.0393204359922 ko05321 Inflammatory bowel disease (IBD) 1/6 56/7206 0.0457468110124